Literature DB >> 27364601

Effect of diastolic dysfunction on postoperative outcomes after cardiovascular surgery: A systematic review and meta-analysis.

Roop Kaw1, Adrian V Hernandez2, Vinay Pasupuleti3, Abhishek Deshpande4, Vijaiganesh Nagarajan5, Hector Bueno6, Craig I Coleman7, John P A Ioannidis8, Deepak L Bhatt9, Eugene H Blackstone10.   

Abstract

OBJECTIVE: The objective of this study was to investigate the effect of preoperative diastolic dysfunction on postoperative mortality and morbidity after cardiovascular surgery.
METHODS: We systematically searched for articles that assessed the prognostic role of diastolic dysfunction on cardiovascular surgery in PubMed, Cochrane Library, Web of Science, Embase, and Scopus until February 2016. Twelve studies (n = 8224) met our inclusion criteria. Because of the scarcity of outcome events, fixed-effects meta-analysis was performed via the Mantel-Haenszel method.
RESULTS: Preoperative diagnosis of diastolic dysfunction was associated with greater postoperative mortality (odds ratio [OR], 2.41; 95% confidence interval [CI], 1.54-3.71; P < .0001), major adverse cardiac events (OR, 2.07; 95% CI, 1.55-2.78; P ≤ .0001), and prolonged mechanical ventilation (OR, 2.08; 95% CI, 1.04-4.16; P = .04) compared with patients without diastolic dysfunction among patients who underwent cardiovascular surgery. The odds of postoperative myocardial infarction (OR, 1.29; 95% CI, 0.82-2.05; P = .28) and atrial fibrillation (OR, 2.67; 95% CI, 0.49-14.43; P = .25) did not significantly differ between the 2 groups. Severity of preoperative diastolic dysfunction was associated with increased postoperative mortality (OR, 21.22; 95% CI, 3.74-120.33; P = .0006) for Grade 3 diastolic dysfunction compared with patients with normal diastolic function. Inclusion of left ventricular ejection fraction (LVEF) <40% accompanying diastolic dysfunction did not further impact postoperative mortality (P = .27; I(2) = 18%) compared with patients with normal LVEF and diastolic dysfunction.
CONCLUSIONS: Presence of preoperative diastolic dysfunction was associated with greater postoperative mortality and major adverse cardiac events, regardless of LVEF. Mortality was significantly greater in grade III diastolic dysfunction.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular surgical procedures; diastolic dysfunction; meta-analysis; mortality

Mesh:

Year:  2016        PMID: 27364601     DOI: 10.1016/j.jtcvs.2016.05.057

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Significance of preoperative right ventricular function on mid-term outcomes after surgical ventricular restoration for ischemic cardiomyopathy.

Authors:  Koji Furukawa; Mitsuhiro Yano; Masanori Nishimura; Eisaku Nakamura; Nozomi Watanabe; Shun Nishino; Kunihide Nakamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-04-09

2.  Medium and long-term prognosis of transcatheter aortic valve implantation from the perspective of left ventricular diastolic function.

Authors:  Satoru Kayama; Shungo Aratake; Shegehito Sawamura; Yusuke Watanabe; Ken Kozuma
Journal:  Cardiol J       Date:  2018-03-23       Impact factor: 2.737

3.  Effect of preoperative left ventricular diastolic dysfunction on mid-term outcomes after surgical ventricular restoration for ischemic cardiomyopathy.

Authors:  Koji Furukawa; Mitsuhiro Yano; Eisaku Nakamura; Masakazu Matsuyama; Masanori Nishimura; Katsuya Kawagoe; Kunihide Nakamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-04-04

4.  Machine Learning-Based Risk Model for Predicting Early Mortality After Surgery for Infective Endocarditis.

Authors:  Li Luo; Sui-Qing Huang; Chuang Liu; Quan Liu; Shuohui Dong; Yuan Yue; Kai-Zheng Liu; Lin Huang; Shun-Jun Wang; Hua-Yang Li; Shaoyi Zheng; Zhong-Kai Wu
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

Review 5.  Heart Failure With Preserved Ejection Fraction: A Perioperative Review.

Authors:  Sasha K Shillcutt; M Megan Chacon; Tara R Brakke; Ellen K Roberts; Thomas E Schulte; Nicholas Markin
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-08-30       Impact factor: 2.628

6.  Preoperative Left Ventricular Diastolic Dysfunction Is Associated with Pulmonary Edema after Carotid Endarterectomy.

Authors:  Kenji Shigematsu; Kouhei Iwashita; Ryosuke Mimata; Ryoko Owaki; Takaaki Totoki; Akira Gohara; Jingo Okawa; Midoriko Higashi; Ken Yamaura
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-05-18       Impact factor: 1.742

7.  Evaluation of left ventricular diastolic function in patients operated for aortic stenosis.

Authors:  Henrik Hultkvist; Eva Nylander; Éva Tamás; Rolf Svedjeholm; Jan Engvall; Jonas Holm; Eva Maret; Farkas Vánky
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

8.  Pre-operative point-of-care assessment of left ventricular diastolic dysfunction, an observational study.

Authors:  Ylva Stenberg; Ylva Rhodin; Anne Lindberg; Roman Aroch; Magnus Hultin; Jakob Walldén; Tomi Myrberg
Journal:  BMC Anesthesiol       Date:  2022-04-05       Impact factor: 2.217

9.  HDAC Inhibition Reverses Preexisting Diastolic Dysfunction and Blocks Covert Extracellular Matrix Remodeling.

Authors:  Joshua G Travers; Sara A Wennersten; Brisa Peña; Rushita A Bagchi; Harrison E Smith; Rachel A Hirsch; Lauren A Vanderlinden; Ying-Hsi Lin; Evgenia Dobrinskikh; Kimberly M Demos-Davies; Maria A Cavasin; Luisa Mestroni; Christian Steinkühler; Charles Y Lin; Steven R Houser; Kathleen C Woulfe; Maggie P Y Lam; Timothy A McKinsey
Journal:  Circulation       Date:  2021-03-08       Impact factor: 29.690

10.  Postoperative pulmonary edema following vitrectomy in patients with ischemic heart disease and diastolic dysfunction in the post-anesthetic care unit: Two case reports.

Authors:  Yuseon Cheong; Namyoong Kim; Minsoo Kim; Hee-Jeong Son; Jin Huh; Seong-Sik Kang; So Young Lim; Byeongmun Hwang
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.